Cardiovascular Center, Korea University, Guro Hospital, Seoul, Korea.
Korean Circ J. 2011 Oct;41(10):565-74. doi: 10.4070/kcj.2011.41.10.565. Epub 2011 Oct 31.
During treatment of acute heart failure (AHF), worsening renal function is often complicated and results in a complex clinical course. Furthermore, renal dysfunction is a strong independent predictor of long-term adverse outcomes in patients with AHF. Traditionally, the predominant cause of renal dysfunction has been attributed to impairment of cardiac output and relative underfilling of arterial perfusion. Recently, emerging data have led to the importance of venous congestion and elevated intra-abdominal pressure rather than confining it to impaired forward cardiac output as the primary driver of renal impairment. Relief of congestion is a major objective of AHF treatment but therapy is still based on the administration of loop diuretics. The results of the recently performed controlled studies for the assessment of new treatments to overcome resistance to diuretic treatment to protect kidneys from untoward effects have been mostly neutral. Better treatment of congestion in heart failure remains a major problem.
在急性心力衰竭(AHF)的治疗过程中,肾功能恶化是常见的并发症,会导致复杂的临床病程。此外,肾功能障碍是 AHF 患者发生长期不良预后的一个强有力的独立预测因素。传统上,肾功能障碍的主要原因被归因于心输出量受损和动脉灌注相对不足。最近,新出现的数据表明,静脉充血和腹内压升高的重要性,而不仅仅是将其局限于心输出量受损,是导致肾功能损害的主要原因。充血的缓解是 AHF 治疗的主要目标,但治疗仍然基于给予袢利尿剂。最近进行的评估新疗法以克服利尿剂抵抗以保护肾脏免受不良影响的对照研究的结果大多为中性。更好地治疗心力衰竭中的充血仍然是一个主要问题。